drugset / Trial / NCT01788176

The Use of Zoledronic Acid to Complex Regional Pain Syndrome

NCT01788176

RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the efficacy and the safety of using a single, intravenous 5mg dose of zoledronic acid in managing pain in Complex Regional Pain Syndrome patients.

Timeline

Start
2013-12
Primary completion
2015-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Zoledronic acid Other / unclassified 5 mg Intravenous